Details for Patent: 5,164,405
✉ Email this page to a colleague
Summary for Patent: 5,164,405
Title: | Nicardipine pharmaceutical composition for parenteral administration |
Abstract: | There is disclosed a stable pharmaceutical composition containing nicardipine hydrochloride, a non-chloride isotonicity agent, a buffering agent and a pharmaceutically acceptable aqueous vehicle for parenteral administration. |
Inventor(s): | McFarlane; Calum B. (Linlithgow, GB6), Selkirk; Alistair B. (Edinburgh, GB6), Dey; Michael J. (East Calder, GB6) |
Assignee: | Syntex (U.S.A.) Inc. (Palo Alto, CA) |
Application Number: | 07/600,277 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; Process; Formulation; Compound; |
Drugs Protected by US Patent 5,164,405
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,164,405
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Belgium | 1003647 | ⤷ Sign Up | |||
Canada | 2011063 | ⤷ Sign Up | |||
United Kingdom | 2228412 | ⤷ Sign Up | |||
United Kingdom | 9004385 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |